Cargando…
Self-injectable extended release formulation of Remdesivir (SelfExRem): A potential formulation alternative for COVID-19 treatment
There has been a growing and evolving research to find a treatment or a prevention against coronavirus 2019 (COVID-19). Though mass vaccination will certainly help in reducing number of COVID-19 patients, an effective therapeutic measure must be available too. Intravenous remdesivir (RDV) was the fi...
Autores principales: | Patki, Manali, Palekar, Siddhant, Reznik, Sandra, Patel, Ketan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948064/ https://www.ncbi.nlm.nih.gov/pubmed/33540028 http://dx.doi.org/10.1016/j.ijpharm.2021.120329 |
Ejemplares similares
-
Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro
por: Vartak, Richa, et al.
Publicado: (2021) -
17-α Hydroxyprogesterone Nanoemulsifying Preconcentrate-Loaded Vaginal Tablet: A Novel Non-Invasive Approach for the Prevention of Preterm Birth
por: Patki, Manali, et al.
Publicado: (2019) -
Tunable Drug Release from Fused Deposition Modelling (FDM) 3D-Printed Tablets Fabricated Using a Novel Extrudable Polymer
por: Raje, Vishvesh, et al.
Publicado: (2022) -
Safety of an extended-release injectable moxidectin suspension formulation (ProHeart(®) 12) in dogs
por: Krautmann, Matthew J., et al.
Publicado: (2019) -
Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly
por: Salvatori, Roberto, et al.
Publicado: (2009)